계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
Recursion Pharmaceuticals
About
Recursion Pharmaceuticals is a digital biology company, developing a drug discovery platform and pipeline with machine learning.
- 101 - 250
Details
- Last Funding Type
- Series B
- Industries
- Artificial Intelligence,Biotechnology,Machine Learning,Pharmaceutical,Therapeutics
- Founded date
- Nov 5, 2013
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. We are a biotechnology company scaling more like a technology company.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 9, 2020 | Series D | $239M | 1 | — | — | Detail |
| Feb 12, 2018 | Series B | — | 1 | — | — | Detail |
| Oct 4, 2017 | Series B | $60M | 1 | — | — | Detail |
| Nov 25, 2015 | Series A | — | 1 | — | — | Detail |
| Feb 25, 2015 | Grant | $1.50M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Advantage Capital
|
— | Series D |
National Institutes of Health
|
— | Grant |
